SLC5A2 and Iron deficiency anemia: International guidelines already recommend testing for and treating iron deficiency in patients with HFrEF.10,11 Although none of our individual findings are definitive, collectively they do raise the question whether testing for and treating iron deficiency after the initiation of SGLT2 inhibition might also be desirable.